The Power of Genome Editing: What Investors Should Know

This article was originally published on ETFTrends.com.

The cost of sequencing a human genome has dropped significantly over the past years and genome editing is enabling new breakthroughs in medicine. On the upcoming webcast, The Power of Genome Editing: What Investors Should Know, Manisha Samy, Analyst Genomic Revolution at ARK Invest, and Renato Leggi, Product Specialist for ARK Invest, will touch upon [...]

Continue Reading Below

Read more at ETFTrends.com >